 BOTHELL, Wash., Sept. 1, 2021 PRNewswire -- BioLife Solutions , Inc. Nasdaq: BLFS BioLife or the Company, a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, announces that it has filed a registration statement on Form S-3 with the Securities and Exchange Commission SEC to register approximately 10.7 million shares of restricted common stock held by stockholders of previously acquired companies Global Cooling, Inc. operating as Stirling Ultracold, SciSafe Holdings, Inc. and Sexton Biotechnologies, Inc., as well as certain shares held by Casdin Capital. 